Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,194 | 74 | -1,575 | -7,106 | -3,867 |
| Depreciation Amortization | 139 | 137 | 214 | 351 | 252 |
| Accounts receivable | -633 | -285 | -221 | 357 | -278 |
| Other Working Capital | -413 | -1,554 | 830 | 432 | 883 |
| Other Operating Activity | 1,358 | 1,136 | 1,579 | 2,732 | 1,593 |
| Operating Cash Flow | $1,645 | $-492 | $827 | $-3,234 | $-1,417 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -50 | -75 | -137 | -36 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -49 |
| Investing Cash Flow | $0 | $-50 | $-75 | $-137 | $-85 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5 | -5 | -79 | -286 | -264 |
| Common Stock Issued | N/A | N/A | N/A | 163 | 501 |
| Other Financing Activity | 0 | 0 | 0 | 157 | 0 |
| Financing Cash Flow | $-5 | $-5 | $-79 | $34 | $237 |
| Exchange Rate Effect | N/A | N/A | N/A | -2 | -11 |
| Beginning Cash Position | 3,760 | 4,307 | 3,634 | 6,973 | 8,249 |
| End Cash Position | 5,400 | 3,760 | 4,307 | 3,634 | 6,973 |
| Net Cash Flow | $1,640 | $-547 | $673 | $-3,339 | $-1,276 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,645 | -492 | 827 | -3,234 | -1,417 |
| Capital Expenditure | N/A | -55 | -75 | -137 | -36 |
| Free Cash Flow | 1,645 | -547 | 752 | -3,371 | -1,453 |